Inventor · disambiguated record
Tobias A. Fuchs
Also filed as: FUCHS TOBIAS · FUCHS TOBIAS A
15 granted patents·13 pending applications·44 citations·filing 2012–2025
90Inventor score
Files withNEUTROLIS INC19CHILDRENS MEDICAL CENTER5UNIV HAMBURG EPPENDORF2HOSOKAWA ALPINE AG1WAGNER DENISA D1
Top patents by PatentIndex Score
28 records- 0190US10696956B2Engineered DNase enzymes and use in therapyNEUTROLIS INC·Filed 2019·Granted Jun 30, 2020·8 cites·25 claims
- 0290US9642822B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisWAGNER DENISA D·Filed 2012·Granted May 9, 2017·26 cites·17 claims
- 0386US10988746B2Manufacturing and engineering of DNASE enzymes for therapyNEUTROLIS INC·Filed 2019·Granted Apr 27, 2021·5 cites·16 claims
- 0482US11464833B2Methods for treating or preventing tissue adhesionsNEUTROLIS INC·Filed 2018·Granted Oct 11, 2022·3 cites·10 claims
- 0582US11046942B2DNase therapy for intravascular accumulation of extracellular DNANEUTROLIS INC·Filed 2020·Granted Jun 29, 2021·1 cites·22 claims
- 0681US10801019B1Engineered DNase enzymes and use in therapyNEUTROLIS INC·Filed 2020·Granted Oct 13, 2020·1 cites·21 claims
- 0780US2024238388A1Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 0879US2025129347A1Engineered human extracellular dnase enzymesNEUTROLIS INC·Filed 2024·Application pending·0 cites
- 0977US2024368569A1Engineered human extracellular dnase enzymes for drug candidate selectionNEUTROLIS INC·Filed 2024·Application pending·0 cites
- 1076US2025262284A1Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 1175US2024374643A1Dnase1-like 3 and its use in therapyNEUTROLIS INC·Filed 2024·Application pending·0 cites
- 1273US11352613B2Engineered human extracellular DNASE enzymesNEUTROLIS INC·Filed 2021·Granted Jun 7, 2022·0 cites·30 claims
- 1371US11046943B2DNase therapy for intravascular accumulation of extracellular DNANEUTROLIS INC·Filed 2020·Granted Jun 29, 2021·0 cites·23 claims
- 1471US2022259579A1Engineered human extracellular dnase enzymesNEUTROLIS INC·Filed 2022·Application pending·0 cites
- 1570US11819540B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2020·Granted Nov 21, 2023·0 cites·30 claims
- 1670US2021277372A1Engineered dnase enzymes and use in therapyNEUTROLIS INC·Filed 2021·Application pending·0 cites
- 1769US11510970B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2020·Granted Nov 29, 2022·0 cites·21 claims
- 1867US11578314B2Engineering of DNASE enzymes for manufacturing and therapyNEUTROLIS INC·Filed 2022·Granted Feb 14, 2023·0 cites·24 claims
- 1966US11840712B2Engineering of DNASE enzymes for manufacturing and therapyNEUTROLIS INC·Filed 2021·Granted Dec 12, 2023·0 cites·19 claims
- 2065US10617742B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 2164US2022132817A1Animal model for drug developmentNEUTROLIS INC·Filed 2022·Application pending·0 cites
- 2263US11058724B2Methods of using DNASE1-like 3 in therapyNEUTROLIS INC·Filed 2020·Granted Jul 13, 2021·0 cites·18 claims
- 2363US2021299178A1Methods of using dnase1-like 3 in therapyNEUTROLIS INC·Filed 2021·Application pending·0 cites
- 2462US2022025343A1Engineered human extracellular dnase enzymes for drug candidate selectionNEUTROLIS INC·Filed 2020·Application pending·0 cites
- 2558US11833523B2Fluidized bed opposed jet mill for producing ultrafine particles from feed material of a low bulk density and a process for use thereofHOSOKAWA ALPINE AG·Filed 2021·Granted Dec 5, 2023·0 cites·12 claims
- 2658US2024228995A9Dnase 1-like 2 engineered for manufacturing and use in therapyNEUTROLIS INC·Filed 2022·Application pending·0 cites
- 2755US2019350178A1Animal model for drug developmentUNIV HAMBURG EPPENDORF·Filed 2018·Application pending·0 cites
- 2836US2019234936A1Immunodiagnostic detection of anti-neutrophil antibodiesUNIV HAMBURG EPPENDORF·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tobias A. Fuchs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →